Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit

Katie Schumm, Sonia Rocha, Jorge Caamano, Neil D. Perkins

    Research output: Contribution to journalArticlepeer-review

    107 Citations (Scopus)


    NOTE: THE SPECIAL CHARACTERS IN THIS ABSTRACT CANNOT BE DISPLAYED CORRECTLY ON THIS PAGE. PLEASE REFER TO THE ABSTRACT ON THE PUBLISHER’S WEBSITE FOR AN ACCURATE DISPLAY. The p52/p100 nuclear factor kappa B (NF-B) subunit (NF-B2) is aberrantly expressed in many tumour types and has been implicated as a regulator of cell proliferation. Here, we demonstrate that endogenous p52 is a direct regulator of Cyclin D1 expression. However, stimulation of Cyclin D1 expression alone cannot account for all the cell cycle effects of p52/p100 and we also find that p52 represses expression of the Cyclin-dependent kinase inhibitor p21WAF/CIP1. Significantly, this latter effect is dependent upon basal levels of the tumour suppressor p53. By contrast, p52 cooperates with p53 to regulate other known p53 target genes such as PUMA, DR5, Gadd45 and Chk1. p52 associates directly with these p53-regulated promoters where it regulates coactivator and corepressor binding. Moreover, recruitment of p52 is p53 dependent and does not require p52-DNA-binding activity. These results reveal a complex role for p52 as regulator of cell proliferation and p53 transcriptional activity. Furthermore, they imply that in some cell types, p52 can regulate p53 function and influence p53-regulated decision-making following DNA damage and oncogene activation.
    Original languageEnglish
    Pages (from-to)4820-4832
    Number of pages13
    JournalThe EMBO Journal
    Issue number20
    Publication statusPublished - Oct 2006


    • Apoptosis
    • Cell cycle
    • Gene expression


    Dive into the research topics of 'Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit'. Together they form a unique fingerprint.

    Cite this